About DexCom, Inc. (DXCM)
DexCom, Inc. is a Medical Devices company operating in the Healthcare sector.
DXCM trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $82.29
- Market Cap
- $30.69B
- 52-Week High
- $92.59
- 52-Week Low
- $54.11
- Sector
- Healthcare
- Industry
- Medical Devices
$1,000 Invested in DexCom, Inc. (DXCM)
How much would $1,000 invested in DXCM be worth today?
What would $1,000 invested in DXCM 1 year ago be worth today?
A $1,000 investment in DexCom, Inc. (DXCM) in 2025 would be worth $1,207 as of November 2026, representing a +20.7% total return.
What would $1,000 invested in DXCM 3 years ago be worth today?
A $1,000 investment in DexCom, Inc. (DXCM) in 2023 would be worth $1,015 as of November 2026, representing a +1.5% total return.
What would $1,000 invested in DXCM 5 years ago be worth today?
A $1,000 investment in DexCom, Inc. (DXCM) in 2021 would be worth $579 as of November 2026, representing a -42.1% total return.
What would $1,000 invested in DXCM 10 years ago be worth today?
A $1,000 investment in DexCom, Inc. (DXCM) in 2016 would be worth $4,080 as of November 2026, representing a +308.0% total return.
What would $1,000 invested in DXCM at IPO be worth today?
A $1,000 investment in DexCom, Inc. (DXCM) at IPO would be worth $28,037 as of November 2026, representing a +2703.8% total return.
Monthly Returns Heatmap
Over the past 21+ years (258 months), DexCom, Inc. (DXCM) has averaged a monthly return of +2.56% with a median return of +1.69%. The stock had 142 positive months (55%) and 116 negative months (45%). The best month in DXCM's history was April 2008 with a +86.0% return, while the worst was November 2008 at -55.8%. Historically, August tends to be the strongest month (averaging +8.4%), and September the weakest (-4.3%).
DXCM's longest winning streak was 11 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 2009 with a cumulative return of +118.6%, and the worst was 2008 at -37.1%.
Annual Returns
Over 21 years of trading history, DexCom, Inc. (DXCM) has delivered an average annual return of +31.81% with a median return of +23.99%. The compound annual growth rate (CAGR) is +15.87%. The stock posted gains in 12 years (57%) and losses in 9 years (43%).
DXCM's best year was 2009 with a +192.39% gain, while the worst was 2008 at -68.74%. The longest streak of consecutive positive years was 4, and the longest losing streak was 3 years. DXCM achieved double-digit gains (10%+) in 11 years. It suffered double-digit losses in 8 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +23.99% | $66.37 | $82.29 |
| 2025 | -14.66% | $77.77 | $66.37 |
| 2024 | -37.33% | $124.09 | $77.77 |
| 2023 | +9.58% | $113.24 | $124.09 |
| 2022 | -15.64% | $134.24 | $113.24 |
| 2021 | +45.23% | $92.43 | $134.24 |
| 2020 | +69.02% | $54.69 | $92.43 |
| 2019 | +82.59% | $29.95 | $54.69 |
| 2018 | +108.75% | $14.35 | $29.95 |
| 2017 | -3.87% | $14.93 | $14.35 |
| 2016 | -27.11% | $20.48 | $14.93 |
| 2015 | +48.77% | $13.76 | $20.48 |
| 2014 | +55.46% | $8.85 | $13.76 |
| 2013 | +160.56% | $3.40 | $8.85 |
| 2012 | +45.97% | $2.33 | $3.40 |
| 2011 | -31.79% | $3.41 | $2.33 |
| 2010 | +69.14% | $2.02 | $3.41 |
| 2009 | +192.39% | $0.69 | $2.02 |
| 2008 | -68.74% | $2.21 | $0.69 |
| 2007 | -10.45% | $2.46 | $2.21 |
| 2006 | -33.91% | $3.73 | $2.46 |
Frequently Asked Questions: DXCM
What sector is DXCM in? ▼
DXCM operates in the Healthcare sector, specifically in the Medical Devices industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has DXCM performed historically? ▼
Over 21 years of trading history, DXCM has posted gains in 12 years (57% of the time). The best year was 2009 with a +192.4% return. Past performance does not guarantee future results.
How can I invest in DXCM? ▼
You can invest in DXCM through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold DXCM.
Last updated: 11/1/2026